Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Profit After Tax (2018 - 2026)

Alector's (ALEC) quarterly Profit After Tax came in at -$23.0 million in Q2 2026, up 24.84% year-over-year from -$18.4 million in Q2 2025, and little changed quarter-over-quarter from -$22.9 million in Q1 2026.

Analysis

Alector (ALEC) Profit After Tax (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Profit After Tax for 9 consecutive years, with -$23.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Profit After Tax rose 24.84% year-over-year to -$23.0 million in Q2 2026; TTM through Jun 2026 was -$117.9 million, a 2.19% decrease from a year earlier, with the FY2025 full-year figure at -$143.0 million, down 20.14% from the prior year.
  • Profit After Tax was -$23.0 million for Q2 2026 at Alector, roughly flat from -$22.9 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $9.9 million in Q2 2022 and troughed at -$50.3 million in Q4 2022.
  • A 5-year average of -$31.7 million and a median of -$38.0 million in 2024 frame the typical range for Profit After Tax.
  • Across the five-year window, Profit After Tax surged 117.92% in 2022 and plunged 2912.8% in 2024, its largest moves.
  • Over 5 years, Profit After Tax stood at -$50.3 million in 2022, then increased by 17.56% to -$41.4 million in 2023, then soared by 94.99% to -$2.1 million in 2024, then tumbled by 1698.36% to -$37.3 million in 2025, then jumped by 38.3% to -$23.0 million in 2026.
  • The last three Profit After Tax figures came in at -$23.0 million (Q2 2026), -$22.9 million (Q1 2026), and -$37.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 472.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 164.49 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 97.50 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -16.62 Mn
10 Alector 274.68 Mn 101.88 Mn - -23.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.01 Mn
Mar 31, 2026 -22.93 Mn
Dec 31, 2025 -37.30 Mn
Sep 30, 2025 -34.67 Mn
Jun 30, 2025 -30.62 Mn
Mar 31, 2025 -40.47 Mn
Dec 31, 2024 -2.07 Mn
Sep 30, 2024 -42.22 Mn
Jun 30, 2024 -38.68 Mn
Mar 31, 2024 -36.08 Mn
Dec 31, 2023 -41.43 Mn
Sep 30, 2023 -44.48 Mn
Jun 30, 2023 1.38 Mn
Mar 31, 2023 -45.86 Mn
Dec 31, 2022 -50.26 Mn
Sep 30, 2022 -46.67 Mn
Jun 30, 2022 9.88 Mn
Mar 31, 2022 -44.62 Mn
Dec 31, 2021 -57.17 Mn
Sep 30, 2021 126.60 Mn